CLOV (Clover Health Investments) ROC (Joel Greenblatt) %: % (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CLOV Clover Health Investments Corp CLOV
82 GF Score
Price $4.54
GF Value $3.98
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Clover Health Investments ROC (Joel Greenblatt) %?

Clover Health Investments CLOV +1.79% 82 ROC (Joel Greenblatt) % is % as of Jun. 2026. GuruFocus rates CLOV with a GF Score™ of 82/100 and a GF Value™ of $3.98 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 15 Healthcare Plans companies, Clover Health Investments ranks worse than 100% on this metric.

ROC (Joel Greenblatt) % does not apply to banks and insurance companies.

CLOV
82GF Score
Clover Health Investments Corp CLOV
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a ROC (Joel Greenblatt) % of % mean?
Clover Health Investments (CLOV) has a ROC (Joel Greenblatt) % of % as of Jun. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Clover Health Investments and its competitors. According to the industry distribution chart, Clover Health Investments ranks #15 out of 15 companies in the Healthcare Plans industry.
Is Clover Health Investments' ROC (Joel Greenblatt) % too high?
Clover Health Investments' current ROC (Joel Greenblatt) % is %. Based on the distribution chart, Clover Health Investments ranks #15 out of 15 companies in the Healthcare Plans industry, which is in the bottom quartile relative to peers. Overall, Clover Health Investments has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clover Health Investments' ROC (Joel Greenblatt) % compare to PGNY and ALHC?
According to the Healthcare Plans industry distribution chart, Clover Health Investments ranks #15 out of 15 companies for ROC (Joel Greenblatt) %. This places Clover Health Investments in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 74.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Plans company?
The median ROC (Joel Greenblatt) % among Healthcare Plans companies is 74.90, based on 15 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Clover Health Investments and its competitors. For the Healthcare Plans industry, the median ROC (Joel Greenblatt) % is 74.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clover Health Investments's current ROC (Joel Greenblatt) % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clover Health Investments stock overvalued right now?
Based on GuruFocus' analysis, Clover Health Investments (CLOV) is currently considered Modestly Overvalued. The stock's GF Value™ is $3.98, compared to a current price of $4.54 — trading 14.1% above its estimated fair value. The current ROC (Joel Greenblatt) % is %. Clover Health Investments' overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Clover Health Investments (CLOV), the current ROC (Joel Greenblatt) % is % as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clover Health Investments (CLOV) Overvalued in 2026?

Based on GuruFocus' analysis, Clover Health Investments stock appears to be overvalued. The current stock price of $4.54 is trading 14.1% above its estimated GF Value™ of $3.98. GuruFocus considers Clover Health Investments to be Modestly Overvalued.

Key valuation signals for CLOV:

  • ROC (Joel Greenblatt) %: %
  • GF Value™: $3.98 vs. price of $4.54 (14.1% above fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the CLOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clover Health Investments Business Description

Other Exchanges 7QD:GermanyCLOV34:Brazil
Address 3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
82GF Score

Get the complete analysis for CLOV

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.54
Price
$3.98
GF Value